RecallDepth
Class I Terminated

1% Lidocaine HCl Injection, USP, 50mg/5mL(10mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4904-11

Company
Pfizer Inc.
Recall Initiated
October 2, 2023
Posted
November 15, 2023
Recall Number
D-0101-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
21,390 vials
Firm Location
New York, NY, United States

Reason for Recall

Presence of Particulate Matter: identified as glass.

Distribution

Nationwide in the US and Puerto Rico. The products were not distributed to government accounts or foreign consignees.

Lot / Code Info

Lot#: 42290DK, Exp. 6/1/2024

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class I Drug recalls